Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

The B cell receptor (BCR) pathway has been identified as a potential therapeutic target in a number of common B cell malignancies, including chronic lymphocytic leukemia, diffuse large B cell lymphoma, Burkitt lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone B cell lymphoma, and Wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Efremov, Dimitar G., Turkalj, Sven, Laurenti, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352865/
https://www.ncbi.nlm.nih.gov/pubmed/32481736
http://dx.doi.org/10.3390/cancers12061396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352865/
https://www.ncbi.nlm.nih.gov/pubmed/32481736
http://dx.doi.org/10.3390/cancers12061396

Ejemplares similares